Korea’s New Health Minister: ‘Golden Time For The Country To Become A Biopharma Leader’

Vows To Reform, Improve Regulations As Part Of Biopharma Growth Strategy

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".